The cystatin C polymorphism is not associated with early onset Alzheimer's disease. 2001

G Roks, and M Cruts, and A J Slooter, and B Dermaut, and A Hofman, and C Van Broeckhoven, and C M Van Duijn
Department of Epidemiology & Biostatistics, Erasmus Medical Center, Rotterdam, The Netherlands.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D015891 Cystatins A homologous group of endogenous CYSTEINE PROTEINASE INHIBITORS. The cystatins inhibit most CYSTEINE ENDOPEPTIDASES such as PAPAIN, and other peptidases which have a sulfhydryl group at the active site. Cystatin,Cystatin Superfamily,Stefin,Cystatin-Related Proteins,Stefins,Type 1 Cystatins,Type 2 Cystatins,Type 3 Cystatins,Type I Cystatins,Type II Cystatins,Type III Cystatins,Cystatin Related Proteins,Cystatins, Type 1,Cystatins, Type 2,Cystatins, Type 3,Cystatins, Type I,Cystatins, Type II,Cystatins, Type III
D055316 Cystatin C An extracellular cystatin subtype that is abundantly expressed in bodily fluids. It may play a role in the inhibition of interstitial CYSTEINE PROTEASES. Cystatin 3,Neuroendocrine Basic Polypeptide,Post-gamma-Globulin,gamma-Trace,Basic Polypeptide, Neuroendocrine,Post gamma Globulin,gamma Trace

Related Publications

G Roks, and M Cruts, and A J Slooter, and B Dermaut, and A Hofman, and C Van Broeckhoven, and C M Van Duijn
May 1993, Neuroscience letters,
G Roks, and M Cruts, and A J Slooter, and B Dermaut, and A Hofman, and C Van Broeckhoven, and C M Van Duijn
April 2002, Neuroscience letters,
G Roks, and M Cruts, and A J Slooter, and B Dermaut, and A Hofman, and C Van Broeckhoven, and C M Van Duijn
January 2007, Neuromolecular medicine,
G Roks, and M Cruts, and A J Slooter, and B Dermaut, and A Hofman, and C Van Broeckhoven, and C M Van Duijn
November 2002, Annals of neurology,
G Roks, and M Cruts, and A J Slooter, and B Dermaut, and A Hofman, and C Van Broeckhoven, and C M Van Duijn
September 2000, Neurology,
G Roks, and M Cruts, and A J Slooter, and B Dermaut, and A Hofman, and C Van Broeckhoven, and C M Van Duijn
September 2003, The Chinese journal of physiology,
G Roks, and M Cruts, and A J Slooter, and B Dermaut, and A Hofman, and C Van Broeckhoven, and C M Van Duijn
December 2004, Journal of Alzheimer's disease : JAD,
G Roks, and M Cruts, and A J Slooter, and B Dermaut, and A Hofman, and C Van Broeckhoven, and C M Van Duijn
January 2010, Neurobiology of aging,
G Roks, and M Cruts, and A J Slooter, and B Dermaut, and A Hofman, and C Van Broeckhoven, and C M Van Duijn
January 1997, Neuroscience letters,
G Roks, and M Cruts, and A J Slooter, and B Dermaut, and A Hofman, and C Van Broeckhoven, and C M Van Duijn
September 1999, Neuroscience letters,
Copied contents to your clipboard!